| ₹ crore | Q1 FY27 | Q1 FY26 | Change |
|---|---|---|---|
| Revenue | 2,988 | 2,503 | +19.4% |
| EBITDA | 170 | 150 | +13.3% |
| EBITDA margin | 5.7% | 6.0% | −0.3 pts |
| Profit before tax | 102 | 71.9 | +42.2% |
| Net profit | 96.8 | 73.3 | +32.2% |
| EPS | ₹14.45 | ₹23.66 | −38.9% |
Amounts on the left scale in ₹ crore; per cent on the right, dashed. L = lakh crore, K = thousand crore. Touch the chart to read any period.
| Tap a line for its trend | Currentlast 12M | FY26Mar 2026 | FY25Mar 2025 | FY24Mar 2024 | FY23Mar 2023 | FY22 and earlierAlpha Plus |
|---|
| 2,221 | — | — | — | — | FY22 and earlierEvery year the company has filed comes with Alpha Plus. | |
| 31.9 | 31.9 | 6.8 | 27.0 | 2.0 | ||
| 1,578 | 1,578 | 1,804 | 1,321 | 1,094 | ||
| 3,768 | — | — | — | — | ||
| 10,312 | 9,827 | 9,039 | 7,922 | 6,642 | ||
| — | +8.7% | +14.1% | +19.3% | — | ||
| 669 | 649 | 511 | 402 | 296 | ||
| 6.5% | 6.6% | 5.7% | 5.1% | 4.5% | ||
| 506 | 494 | 396 | 302 | 202 | ||
| 316 | 293 | 231 | 173 | 141 | ||
| 3.1% | 3.0% | 2.6% | 2.2% | 2.1% | ||
| ₹47.20 | ₹43.68 | ₹34.46 | ₹25.81 | ₹18.66 | ||
| — | +26.8% | +33.5% | +38.3% | — | ||
| — | 769 | 362 | 439 | 326 | ||
| — | −823 | −760 | −553 | −439 | ||
| −54.3 | −54.3 | −398 | −114 | −113 | ||
From the company's filings with NSE and BSE (Ind-AS), consolidated. For information only, not investment advice.
In ₹ Crore except Per Share 12 Months Ending | FY23 31/03/2023 | FY24 31/03/2024 | FY25 31/03/2025 | FY26 31/03/2026 | Current/LTM TTM · last close | |
|---|---|---|---|---|---|---|
| Market Capitalization | — | — | — | — | 2,221.4 | |
| - Cash, Equiv & ST Investments | 2.0 | 27.0 | 6.8 | 31.9 | 31.9 | |
| + Total Debt | 1,094.1 | 1,321.1 | 1,804.3 | 1,578.5 | 1,578.5 | |
| Enterprise Value | — | — | — | — | 3,768.0 | |
| Revenue | 6,641.6 | 7,921.5 | 9,039.0 | 9,826.6 | 10,312.0 | |
| Growth %, YoY | — | +19.3 | +14.1 | +8.7 | — | |
| EBITDA | 295.5 | 402.4 | 510.9 | 649.3 | 669.2 | |
| Margin % | 4.45 | 5.08 | 5.65 | 6.61 | 6.49 | |
| EBIT | 201.6 | 301.6 | 395.7 | 493.9 | 505.8 | |
| Net Income | 141.0 | 173.0 | 230.9 | 292.8 | 316.3 | |
| Margin % | 2.12 | 2.18 | 2.55 | 2.98 | 3.07 | |
| EPS, Adj (current shares) | 18.66 | 25.81 | 34.46 | 43.68 | 47.20 | |
| Growth %, YoY | — | +38.3 | +33.5 | +26.8 | — | |
| Cash from Operations | 325.7 | 438.5 | 362.1 | 769.2 | — | |
| Capital Expenditures | -438.8 | -552.9 | -760.5 | -823.5 | — | |
| Free Cash Flow | -113.1 | -114.4 | -398.4 | -54.3 | -54.3 | |
Prices at the 29 October 2026 close · figures from the company's filings with NSE
India Glycols (NSE: INDIAGLYCO) had a market capitalisation of ₹2,214 crore at the 29 October 2026 close (₹330.30 a share), a PE ratio of 7.0 on the last four quarters' profit and a price-to-book ratio of 0.75. In FY26 its consolidated net profit was ₹293 crore on revenue of ₹9,827 crore; in Q1 FY27 (April–June 2026) it was ₹96.8 crore, up 32.2% year on year. Its debt-to-equity ratio was 0.54 on 31 March 2026. Promoters held 59.63% of the shares on 30 September 2026.
India Glycols' PE ratio is 7.0 at the 29 October 2026 close (₹330.30 a share): a market capitalisation of ₹2,214 crore divided by consolidated net profit of ₹316 crore over the last four quarters (Q2 FY26 to Q1 FY27). On FY26 net profit (₹293 crore) it is 7.6.
India Glycols' debt-to-equity ratio was 0.54 on 31 March 2026: borrowings of ₹1,578 crore against total equity of ₹2,933 crore. A year earlier, on 31 March 2025, it was 0.80.
India Glycols' net worth — shareholders' equity in its consolidated balance sheet — was ₹2,933 crore on 31 March 2026, up 30.0% from ₹2,256 crore a year earlier. Its market value is a different figure: a market capitalisation of ₹2,214 crore at the 29 October 2026 close.
India Glycols' price-to-book (PB) ratio is 0.75 at the 29 October 2026 close: a market capitalisation of ₹2,214 crore divided by shareholders' equity (book value) of ₹2,933 crore on 31 March 2026. That is a book value of ₹437.60 per share against a share price of ₹330.30.
In FY26, India Glycols' return on equity (ROE) was 11.3% and its return on capital employed (ROCE) was 11.8%. ROE is net profit divided by average shareholders' equity (the start and end of the year); ROCE is operating profit (EBIT) divided by average capital employed (total assets less current liabilities). In FY25, ROE was 10.7% and ROCE 11.2%.
India Glycols' book value per share was ₹437.60 on 31 March 2026: shareholders' equity of ₹2,933 crore divided by the 6.7 crore shares in issue. The share price at the 29 October 2026 close was ₹330.30.
India Glycols' market capitalisation was ₹2,214 crore at the 29 October 2026 close: 6.7 crore shares at ₹330.30 each.
No. India Glycols had borrowings of ₹1,578 crore on 31 March 2026 (consolidated balance sheet), a debt-to-equity ratio of 0.54. Its cash and current investments were ₹49.8 crore, so its net debt was ₹1,529 crore.
In 2026, India Glycols has declared one dividend: ₹7.50 (interim) with record date 23 March 2026.
India Glycols' basic earnings per share (EPS) were ₹45.95 in FY26.
Promoters held 59.63% of India Glycols on 30 September 2026, unchanged from the previous quarter and down 1.38 percentage points from 61.01% a year earlier, according to the shareholding pattern filed with NSE.
India Glycols has not yet announced the date of its Q2 FY27 results (July–September 2026); under SEBI's listing rules (Regulation 33) they are due by 14 November 2026.
On 30 September 2026, India Glycols' shares were held by promoters 59.63%, foreign portfolio investors (FII/FPI) 2.76%, domestic institutions (DII) 3.05% (including mutual funds at 0.10%) and retail and other non-institutional investors 34.55%. Over the year, FII holding was up 0.14 percentage points from 2.62% and DII holding was up 1.72 percentage points from 1.33%.
India Glycols' latest results are for Q1 FY27 (April–June 2026), filed on 12 August 2026: consolidated net profit ₹96.8 crore, up 32.2% from ₹73.3 crore in Q1 FY26; revenue from operations ₹2,988 crore, up 19.4% year on year.
At the 29 October 2026 closing prices, on FY26 net profit, India Glycols' PE ratio is 7.6, the lowest of the four: Balrampur Chini Mills 35.5, Heritage Foods 21.9 and Gokul Agro Resources 17.3, a peer average of 24.9. Each is the company's market capitalisation at that price divided by its FY26 net profit.
In FY26, India Glycols generated ₹769 crore of cash from operations and spent ₹823 crore on capital expenditure (property, plant, equipment and intangibles), leaving free cash flow of −₹54.3 crore. In FY25 it was −₹398 crore.
In FY26 (April 2025–March 2026), India Glycols' consolidated net profit was ₹293 crore, up 26.8% from ₹231 crore in FY25, on revenue from operations of ₹9,827 crore (up 8.7%). Over three years, from FY23, net profit was up 134.1%.
In FY26, India Glycols earned net profit of ₹293 crore on revenue of ₹9,827 crore, against ₹378 crore on ₹6,271 crore for Balrampur Chini Mills. India Glycols' operating margin was 5.0% (Balrampur Chini Mills 9.0%) and its return on equity 11.3% (Balrampur Chini Mills 9.5%). At the 29 October 2026 close, India Glycols' market capitalisation was ₹2,214 crore against ₹13,420 crore for Balrampur Chini Mills, and its PE ratio on FY26 profit 7.6 against 35.5.
On FY26 consolidated figures, against Balrampur Chini Mills, Heritage Foods and Gokul Agro Resources: India Glycols' operating margin of 5.0% is the second highest of the four (Balrampur Chini Mills 9.0%, Heritage Foods 4.1%, Gokul Agro Resources 2.6%; peer average 5.2%); its return on equity of 11.3% is the third highest of the four (Balrampur Chini Mills 9.5%, Heritage Foods 14.5%, Gokul Agro Resources 30.1%; peer average 18.0%); its revenue growth over three years of 14.0% a year is the second highest of the four (Balrampur Chini Mills 10.4% a year, Heritage Foods 11.8% a year, Gokul Agro Resources 30.9% a year; peer average 17.7% a year).
From India Glycols' own consolidated results, balance sheets and shareholding patterns filed with NSE, and NSE prices (the latest used here: the 29 October 2026 close). Ratios are calculated by Alphave from those filings as each answer describes.
Consolidated figures from the company's filings with NSE; prices are NSE closing prices.